Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Published:2021-02 Issue:2 Volume:20 Page:98-106
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Fehlings Michael G,Badhiwala Jetan H,Ahn Henry,Farhadi H Francis,Shaffrey Christopher I,Nassr Ahmad,Mummaneni Praveen,Arnold Paul M,Jacobs W Bradley,Riew K Daniel,Kelly Michael,Brodke Darrel S,Vaccaro Alexander R,Hilibrand Alan S,Wilson Jason,Harrop James S,Yoon S Tim,Kim Kee D,Fourney Daryl R,Santaguida Carlo,Massicotte Eric M,Kopjar Branko

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference37 articles.

1. Degenerative cervical myelopathy - update and future directions;Badhiwala;Nat Rev Neurol,2020

2. Degenerative cervical myelopathy;Davies;BMJ,2018

3. Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy;Yu;Brain,2011

4. The pathophysiology of degenerative cervical myelopathy and the physiology of recovery following decompression;Akter;Front Neurosci,2020

5. Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy;Karadimas;Sci Transl Med,2015

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Therapy for Spinal Cord Injury;Clinical Spine Surgery;2024-09-12

2. Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study;JMIR Neurotechnology;2024-09-09

3. Machine learning-based cluster analysis identifies four unique phenotypes of patients with degenerative cervical myelopathy with distinct clinical profiles and long-term functional and neurological outcomes;eBioMedicine;2024-08

4. Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence;Neurospine;2024-06-30

5. Potential thresholds of critically increased cardiac-related spinal cord motion in degenerative cervical myelopathy;Frontiers in Neurology;2024-06-24